propofol has been researched along with Hematologic Neoplasms in 4 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We sought to determine whether the combination of propofol and fentanyl results in lower propofol doses and fewer adverse cardiopulmonary events than propofol and placebo for lumbar puncture in children with acute hematologic malignancies." | 9.13 | Propofol-fentanyl versus propofol alone for lumbar puncture sedation in children with acute hematologic malignancies: propofol dosing and adverse events. ( Christenson, DK; Eickhoff, JC; Hollman, GA; Schultz, MM, 2008) |
| "We sought to determine whether the combination of propofol and fentanyl results in lower propofol doses and fewer adverse cardiopulmonary events than propofol and placebo for lumbar puncture in children with acute hematologic malignancies." | 5.13 | Propofol-fentanyl versus propofol alone for lumbar puncture sedation in children with acute hematologic malignancies: propofol dosing and adverse events. ( Christenson, DK; Eickhoff, JC; Hollman, GA; Schultz, MM, 2008) |
| " There has been no report on adverse events after discharge from the recovery room." | 1.72 | Delayed Adverse Events after Procedural Sedation in Pediatric Patients with Hematologic Malignancies. ( Joo, J; Koh, HJ; Yu, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joo, J | 1 |
| Yu, S | 1 |
| Koh, HJ | 1 |
| Ince, IE | 1 |
| Iyilikci, L | 1 |
| Yilmaz, S | 1 |
| Güneş, D | 1 |
| Akkuş, M | 1 |
| Isguven, D | 1 |
| Hollman, GA | 1 |
| Schultz, MM | 1 |
| Eickhoff, JC | 1 |
| Christenson, DK | 1 |
| Keidan, I | 1 |
| Berkenstadt, H | 1 |
| Sidi, A | 1 |
| Perel, A | 1 |
3 trials available for propofol and Hematologic Neoplasms
| Article | Year |
|---|---|
Sedation for short hemato-oncologic invasive procedures in children: comparison of propofol-remifentanil and propofol-fentanyl.
Topics: Adolescent; Analgesics, Opioid; Blood Pressure; Child; Child, Preschool; Conscious Sedation; Female; | 2013 |
Propofol-fentanyl versus propofol alone for lumbar puncture sedation in children with acute hematologic malignancies: propofol dosing and adverse events.
Topics: Adjuvants, Anesthesia; Adolescent; Anesthetics, Intravenous; Child; Child, Preschool; Cross-Over Stu | 2008 |
Propofol/remifentanil versus propofol alone for bone marrow aspiration in paediatric haemato-oncological patients.
Topics: Adolescent; Analgesics, Opioid; Anesthesia, Intravenous; Anesthetics, Intravenous; Biopsy, Needle; B | 2001 |
1 other study available for propofol and Hematologic Neoplasms
| Article | Year |
|---|---|
Delayed Adverse Events after Procedural Sedation in Pediatric Patients with Hematologic Malignancies.
Topics: Child; Emergency Service, Hospital; Hematologic Neoplasms; Humans; Hypnotics and Sedatives; Ketamine | 2022 |